26 matches.
- EventsMedicaid Drug Rebate Program Summit: Operationalizing the IRA from a 101 Perspective1 minute read
- BlogsCMS Rules Propose Changes Regarding the Medicare Prescription Drug Inflation Rebate Program, Refundable Drugs, Skin Supplements and More; Comments Due September 913 minute read
- PublicationsThe IRA: Reducing Inflation or Threatening Patient Access?2 minute read
- EventsAPhA2024: The Inflation Reduction Act - Implications for Pharmacy2 minute read
- PublicationsCMS Seeks Stakeholder Feedback About Medicare Transaction Facilitator Services for the Medicare Drug Price Negotiation Program by November 13: Inflation Reduction Act Updates4 minute read
- Media CoverageRichard Hughes, Will Walters Quoted in “SCOTUS Cases Could Create ‘Fractured’ Health Care Policy Landscape”2 minute read
Game-Changing IRA: Revolutionizing Prescription Drug Pricing and Medicare Benefits- EventsIFEBP Employee Benefits Conference: The Future of Prescription Drug Pricing Policy2 minute read
Inflation Reduction Act’s Drug Price Negotiation Provisions – What Now?- Media CoverageRachel Snyder Good Featured in “The Top Mid-Law People Moves of 2023 So Far”2 minute read
- PublicationsCMS Releases Its List of 43 Part B Rebatable Drugs for Q3: Inflation Reduction Act Updates7 minute read
- PublicationsManufacturers Must Request Small Biotech Exception by July 3: Inflation Reduction Act Updates4 minute read
- PublicationsCMS Seeks Comment on Initial Guidance for the Part D Manufacturer Discount Program: Inflation Reduction Act Updates2 minute read
- EventsMedicaid and Government Pricing Congress2 minute read
- BlogsPodcast: Inflation Reduction Act’s Drug Price Negotiation Provisions – What’s Next? - Diagnosing Health Care3 minute read
-
Inflation Reduction Act’s Drug Price Negotiation Provisions – What’s Next?
- PublicationsCMS Issues an Information Collection Request for the Drug Price Negotiation Process: Inflation Reduction Act Updates3 minute read
- PublicationsIs CMS Ignoring the Realities of Biopharmaceutical Costs?2 minute read
- PublicationsCMS’s Initial Guidance on Medicare Drug Price Negotiation Program Suggests Familiar Pharmacy Chargeback Process12 minute read
- PublicationsCMS Issues an Information Collection Request on Negotiation Data Elements: Inflation Reduction Act Updates3 minute read
- BlogsIs CMS Ignoring the Realities of Biopharmaceutical Costs?6 minute read
- PublicationsCMS Issues New Guidance on Medicare Drug Price Negotiation Program: Inflation Reduction Act Updates2 minute read
- PublicationsCMS Releases Its List of 27 Part B Rebatable Drugs for Q2 of 2023: Inflation Reduction Act Updates3 minute read
- BlogsComments to CMS Guidance on the Medicare Prescription Drug Inflation Rebate Program Due March 11, 202310 minute read
- PublicationsCMS Launches First Federal Regulatory Action to Implement Medicare Drug Price Negotiation Program6 minute read
-
2023 Health Policy Outlook